Login to Your Account



Burr floats clawback for appropriations in FDA user fee deals

By Mark McCarty
Regulatory Editor

Tuesday, April 4, 2017

The Senate hearing dealing with FDA user fees covered much of the predictable ground, but Sen. Richard Burr (R-N.C.) gave voice to the prospect that the user fee-authorizing legislation would incorporate a clawback mechanism for appropriations should the agency fail to meet the goals of the next set of user fee agreements.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription